CTLA4 and hepatocellular carcinoma: Additionally, this study demonstrated that carriers of CTLA-4-319*T allele had 1.6 times higher risk of HCC in comparison to individuals with C/C genotype, this risk increased to 2.6 in case of T/T homozygotes.